Transitional Year·Bradenton, FL

HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa South/Blake Hospital

Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
246–269
p10 – p90
Sample N
715
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
1.7%
12 of 715 applicants
01Cohort funnelthis cycle
N = 715
Applied
715
100.0%
Invited
140
19.6%
Class size
12
1.7%
J-1 visaGraduated within 3 yearsPreliminary
Your fitHCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa South/Blake Hospital Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at HCA Florida Healthcare

Create free account

Who to contact

Training sites3 hospitals · Bradenton
  • 1
    HCA Florida Blake Hospital
    Bradenton, FL
    Primary
  • 2
    HCA Florida Healthcare/USF Morsani College of Medicine GME
    Tampa, FL
    Sponsor
  • 3
    Pinnacle Medical Group
    Bradenton, FL
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK246 – 269
180205230255280
COMLEX Level 2 CE532 – 679
400500600700800
Interview rates
US MD
31%
US DO
15%
US IMG
0%
Non-US IMG
3%
Applicant origin
In-state
40%
Out-of-state
14%
Interview prepTransitional Year
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa South/Blake Hospital to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Transitional Year.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.